Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Strain label, Claim.
- Who it may be relevant to
- Registry conditions: Cannabis Use. Basic parameters: from 21 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study looks at how cannabis product label and marketing claims affect product perceptions, use expectancies, and use intentions among inexperienced and experienced cannabis users. Participants will answer online survey questions on their perceptions of a cannabis product advertisement.
Detailed description
This study aims to specify how product label and marketing claims affect product perceptions, use expectancies, and use intentions among cannabis users. A randomized 4 (Sativa, Indica, Hybrid, no strain label) x 3 (energizing, sedative, no claim) online experiment will be conducted with a sample of adults from states that have legalized adult cannabis recreational use. Our main research questions are: (1) Do label and marketing claim affect (a) harm perceptions, (b) subjective effects expectancies (e.g., arousal, sedation), (c) willingness to use, and (d) willingness to use during daily activities (e.g., driving)? and (2) Do label and marketing claim interact to affect product perceptions, use expectancies, and use intentions?
Interventions
- Other Strain label
Presentation of strain label on cannabis advertising material - Other Claim
Presentation of claim on cannabis advertising material
Primary outcome measures
- Harm perception - One time use [Time frame: Immediately after viewing ad]
- Harm perception - Daily use [Time frame: Immediately after viewing ad]
- Expectancy effects [Time frame: Immediately after viewing ad]
- Willingness to use [Time frame: Immediately after viewing ad]
- Willingness to use during daily activities [Time frame: Immediately after viewing ad]
Eligibility criteria
Inclusion criteria
- Age = 21+
- Live in in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented
- For inexperienced users: lifetime cannabis use >1 \& <= 10
- For experienced users: lifetime cannabis use>10 \& <100, past month cannabis use>0
Exclusion criteria
- Under age 21
- Does not live in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented
- Lifetime cannabis use >=100 times
- Lifetime cannabis use <1 time
- Lifetime cannabis use>10 \& <100 AND past month cannabis use=0
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Open label
- Primary purpose
- Other
Study locations
United States · 1 center
- 2213 McElderry St. — Baltimore
Identifiers
NCT: NCT07513337 · IRB00034819 · 5R01DA059584